CXCL12 inhibits expression of the NMDA receptor's NR2B subunit through a histone deacetylase-dependent pathway contributing to neuronal survival
10.1038/cddis.2010.10
Crossref journal-article
Springer Science and Business Media LLC
Cell Death & Disease (297)
Bibliography

Nicolai, J., Burbassi, S., Rubin, J., & Meucci, O. (2010). CXCL12 inhibits expression of the NMDA receptor’s NR2B subunit through a histone deacetylase-dependent pathway contributing to neuronal survival. Cell Death & Disease, 1(4), e33–e33.

Authors 4
  1. J Nicolai (first)
  2. S Burbassi (additional)
  3. J Rubin (additional)
  4. O Meucci (additional)
References 41 Referenced 53
  1. Kaul M, Lipton SA . Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 2006; 4: 307–318. (10.2174/157016206777709384) / Curr HIV Res by M Kaul (2006)
  2. Greenwood SM, Connolly CN . Dendritic and mitochondrial changes during glutamate excitotoxicity. Neuropharmacology 2007; 53: 891–898. (10.1016/j.neuropharm.2007.10.003) / Neuropharmacology by SM Greenwood (2007)
  3. Waxman EA, Lynch DR . N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005; 11: 37–49. (10.1177/1073858404269012) / Neuroscientist by EA Waxman (2005)
  4. Wollmuth LP, Sobolevsky AI . Structure and gating of the glutamate receptor ion channel. Trends Neurosci 2004; 27: 321–328. (10.1016/j.tins.2004.04.005) / Trends Neurosci by LP Wollmuth (2004)
  5. Burnashev N . Calcium permeability of glutamate-gated channels in the central nervous system. Curr Opin Neurobiol 1996; 6: 311–317. (10.1016/S0959-4388(96)80113-9) / Curr Opin Neurobiol by N Burnashev (1996)
  6. Sattler R, Tymianski M . Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 2001; 24: 107–129. (10.1385/MN:24:1-3:107) / Mol Neurobiol by R Sattler (2001)
  7. Villmann C, Becker CM . On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist 2007; 13: 594–615. (10.1177/1073858406296259) / Neuroscientist by C Villmann (2007)
  8. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH . Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994; 12: 529–540. (10.1016/0896-6273(94)90210-0) / Neuron by H Monyer (1994)
  9. Tovar KR, Westbrook GL . Mobile NMDA receptors at hippocampal synapses. Neuron 2002; 34: 255–264. (10.1016/S0896-6273(02)00658-X) / Neuron by KR Tovar (2002)
  10. Miwa H, Fukaya M, Watabe AM, Watanabe M, Manabe T . Functional contributions of synaptically localized NR2B subunits of the NMDA receptor to synaptic transmission and long-term potentiation in the adult mouse CNS. J Physiol 2008; 586: 2539–2550. (10.1113/jphysiol.2007.147652) / J Physiol by H Miwa (2008)
  11. Leveille F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O et al. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J 2008; 22: 4258–4271. (10.1096/fj.08-107268) / FASEB J by F Leveille (2008)
  12. Bading H, Ginty DD, Greenberg ME . Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993; 260: 181–186. (10.1126/science.8097060) / Science by H Bading (1993)
  13. Hardingham GE, Fukunaga Y, Bading H . Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002; 5: 405–414. (10.1038/nn835) / Nat Neurosci by GE Hardingham (2002)
  14. Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E et al. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 2004; 24: 7821–7828. (10.1523/JNEUROSCI.1697-04.2004) / J Neurosci by PV Massey (2004)
  15. Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y et al. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol 2006; 572 (Part 3): 789–798. (10.1113/jphysiol.2006.105510) / J Physiol by A Ivanov (2006)
  16. Li M, Ransohoff RM . Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 2008; 84: 116–131. (10.1016/j.pneurobio.2007.11.003) / Prog Neurobiol by M Li (2008)
  17. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001; 4: 702–710. (10.1038/89490) / Nat Neurosci by P Bezzi (2001)
  18. Bhattacharyya BJ, Banisadr G, Jung H, Ren D, Cronshaw DG, Zou Y et al. The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J Neurosci 2008; 28: 6720–6730. (10.1523/JNEUROSCI.1677-08.2008) / J Neurosci by BJ Bhattacharyya (2008)
  19. Khan MZ, Brandimarti R, Shimizu S, Nicolai J, Crowe E, Meucci O . The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ 2008; 15: 1663–1672. (10.1038/cdd.2008.95) / Cell Death Differ by MZ Khan (2008)
  20. Shimizu S, Khan MZ, Hippensteel RL, Parkar A, Raghupathi R, Meucci O . Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiol Dis 2007; 25: 17–26. (10.1016/j.nbd.2006.08.004) / Neurobiol Dis by S Shimizu (2007)
  21. Qiu Z, Ghosh A . A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. Neuron 2008; 60: 775–787. (10.1016/j.neuron.2008.09.040) / Neuron by Z Qiu (2008)
  22. Meucci O, Miller RJ . gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci 1996; 16: 4080–4088. (10.1523/JNEUROSCI.16-13-04080.1996) / J Neurosci by O Meucci (1996)
  23. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ . Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 2002; 123: 66–75. (10.1016/S0165-5728(01)00485-4) / J Neuroimmunol by SB Oh (2002)
  24. Sattler R, Charlton MP, Hafner M, Tymianski M . Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem 1998; 71: 2349–2364. (10.1046/j.1471-4159.1998.71062349.x) / J Neurochem by R Sattler (1998)
  25. Papadia S, Hardingham GE . The dichotomy of NMDA receptor signaling. Neuroscientist 2007; 13: 572–579. (10.1177/1073858407305833) / Neuroscientist by S Papadia (2007)
  26. Saha RN, Pahan K . HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006; 13: 539–550. (10.1038/sj.cdd.4401769) / Cell Death Differ by RN Saha (2006)
  27. Burbassi S, Aloyo VJ, Simansky KJ, Meucci O . GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4. J Neuroimmune Pharmacol 2008; 3: 26–34. (10.1007/s11481-007-9083-1) / J Neuroimmune Pharmacol by S Burbassi (2008)
  28. Sengupta R, Burbassi S, Shimizu S, Cappello S, Vallee RB, Rubin JB et al. Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J Neurosci 2009; 29: 2534–2544. (10.1523/JNEUROSCI.5865-08.2009) / J Neurosci by R Sengupta (2009)
  29. Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB . Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Res 2005; 65: 11392–11399. (10.1158/0008-5472.CAN-05-0847) / Cancer Res by BM Woerner (2005)
  30. Lynch DR, Guttmann RP . NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets 2001; 2: 215–231. (10.2174/1389450013348434) / Curr Drug Targets by DR Lynch (2001)
  31. Zhang SJ, Steijaert MN, Lau D, Schutz G, Delucinge-Vivier C, Descombes P et al. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 2007; 53: 549–562. (10.1016/j.neuron.2007.01.025) / Neuron by SJ Zhang (2007)
  32. Kim MJ, Dunah AW, Wang YT, Sheng M . Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 2005; 46: 745–760. (10.1016/j.neuron.2005.04.031) / Neuron by MJ Kim (2005)
  33. Stocca G, Vicini S . Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol 1998; 507 (Part 1): 13–24. (10.1111/j.1469-7793.1998.013bu.x) / J Physiol by G Stocca (1998)
  34. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME . Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999; 286: 1358–1362. (10.1126/science.286.5443.1358) / Science by A Bonni (1999)
  35. Hardingham GE, Arnold FJ, Bading H . A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci 2001; 4: 565–566. (10.1038/88380) / Nat Neurosci by GE Hardingham (2001)
  36. Miller RJ, Rostene W, Apartis E, Banisadr G, Biber K, Milligan ED et al. Chemokine action in the nervous system. J Neurosci 2008; 28: 11792–11795. (10.1523/JNEUROSCI.3588-08.2008) / J Neurosci by RJ Miller (2008)
  37. Melik-Parsadaniantz S, Rostene W . Chemokines and neuromodulation. J Neuroimmunol 2008; 198: 62–68. (10.1016/j.jneuroim.2008.04.022) / J Neuroimmunol by S Melik-Parsadaniantz (2008)
  38. Thomas GM, Huganir RL . MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 2004; 5: 173–183. (10.1038/nrn1346) / Nat Rev Neurosci by GM Thomas (2004)
  39. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 2007; 27: 2846–2857. (10.1523/JNEUROSCI.0116-07.2007) / J Neurosci by Y Liu (2007)
  40. Langley B, D’Annibale MA, Suh K, Ayoub I, Tolhurst A, Bastan B et al. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection. J Neurosci 2008; 28: 163–176. (10.1523/JNEUROSCI.3200-07.2008) / J Neurosci by B Langley (2008)
  41. Salminen A, Tapiola T, Korhonen P, Suuronen T . Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res Mol Brain Res 1998; 61: 203–206. (10.1016/S0169-328X(98)00210-1) / Brain Res Mol Brain Res by A Salminen (1998)
Dates
Type When
Created 15 years, 5 months ago (April 1, 2010, 6 a.m.)
Deposited 2 years, 7 months ago (Jan. 5, 2023, 7:17 p.m.)
Indexed 2 weeks ago (Aug. 19, 2025, 7:10 a.m.)
Issued 15 years, 5 months ago (April 1, 2010)
Published 15 years, 5 months ago (April 1, 2010)
Published Online 15 years, 5 months ago (April 1, 2010)
Funders 0

None

@article{Nicolai_2010, title={CXCL12 inhibits expression of the NMDA receptor’s NR2B subunit through a histone deacetylase-dependent pathway contributing to neuronal survival}, volume={1}, ISSN={2041-4889}, url={http://dx.doi.org/10.1038/cddis.2010.10}, DOI={10.1038/cddis.2010.10}, number={4}, journal={Cell Death & Disease}, publisher={Springer Science and Business Media LLC}, author={Nicolai, J and Burbassi, S and Rubin, J and Meucci, O}, year={2010}, month=apr, pages={e33–e33} }